Transcat, Inc.
TRNS
Positions held
Your positionsTRNS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $808.69M | Enterprise value | $945.23M | Trailing P/E | 240.00 | Forward P/E | 39.86 |
| PEG | — | Price / book | 2.68 | Beta | 0.66 | Dividend yield | 0.00% |
| Revenue growth | 21.6% | Earnings growth | -60.0% | Gross margin | 32.5% | Operating margin | 5.5% |
| Profit margin | 1.0% | ROE | 1.2% | ROA | 2.2% | Debt / equity | 0.47 |
| Current ratio | 2.49 | Free cash flow | $27.98M | Analyst recommendation | none | Mean target | $104.33 |
| 52w high | $100.00 | 52w low | $50.23 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $92.9M | $89.3M | $83.9M | $82.3M | $76.4M |
| Op margin | 4.0% | 4.8% | 0.1% | 4.3% | 7.0% |
| Net income | $1.3M | $1.9M | -$1.1M | $1.3M | $3.3M |
| Gross margin | 33.1% | 34.1% | 30.1% | 32.5% | 33.8% |
| Gross profit | $30.7M | $30.5M | $25.3M | $26.8M | $25.8M |
| Operating income | $3.7M | $4.3M | $0.1M | $3.5M | $5.3M |
- Revenue +4% vs prior quarter ($93M vs $89M).
- Gross margin 33.1% (was 34.1% prior quarter).
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $332M | $278M | $259M | $231M |
| Op margin | 4.0% | 6.4% | 7.6% | 7.0% |
| Net income | $5.4M | $14.5M | $13.6M | $10.7M |
| Gross margin | 32.6% | 32.1% | 32.3% | 29.6% |
| Gross profit | $108M | $89.5M | $83.8M | $68.4M |
| Operating income | $13.3M | $17.9M | $19.8M | $16.2M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-29 · 1 Growth Stock with All-Star Potential and 2 We Ignore
2026-09-28 · 1 Small-Cap Stock on Our Buy List and 2 Facing Challenges
2026-09-22 · 3 Reasons to Sell TRNS and 1 Stock to Buy Instead
2026-09-14 · 1 Industrials Stock to Keep an Eye On and 2 We Turn Down
2026-09-08 · 3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
2026-08-31 · 1 Profitable Stock with Solid Fundamentals and 2 We Find Risky
2026-08-31 · Transcat Acquires Southeastern Biomedical Associates For $12.8 Million
2026-08-31 · Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical
2026-08-27 · Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September
2026-08-13 · 5 Revealing Analyst Questions From Transcat’s Q2 Earnings Call
2026-08-12 · Transcat (TRNS) Q1 2027 Earnings Call Transcript
2026-08-05 · Transcat Inc (TRNS) (Q1 2027) Earnings Call Highlights: Strong Service Growth and Strategic ...
Price (daily)
Full chart · RSI · MACD · patterns